182 related articles for article (PubMed ID: 35122145)
1. Physical function and physical activity in adults with X-linked hypophosphatemia.
Orlando G; Bubbear J; Clarke S; Keen R; Roy M; Anilkumar A; Schini M; Walsh JS; Javaid MK; Ireland A
Osteoporos Int; 2022 Jul; 33(7):1485-1491. PubMed ID: 35122145
[TBL] [Abstract][Full Text] [Related]
2. Impaired Physical Performance in X-linked Hypophosphatemia Is not Caused by Depleted Muscular Phosphate Stores.
Kara JAS; Zange J; Hoffman F; Tank J; Jordan J; Semler O; Schönau E; Rittweger J; Seefried L
J Clin Endocrinol Metab; 2023 Jun; 108(7):1634-1645. PubMed ID: 37043477
[TBL] [Abstract][Full Text] [Related]
3. Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH).
Glorieux FH; Bonewald LF; Harvey NC; van der Meulen MCH
Orphanet J Rare Dis; 2022 Jan; 17(1):30. PubMed ID: 35101067
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life of X-linked hypophosphatemia in Spain.
Yanes MIL; Diaz-Curiel M; Peris P; Vicente C; Marin S; Ramon-Krauel M; Hernandez J; Broseta JJ; Espinosa L; Mendizabal S; Perez-Sukia L; Martínez V; Palazón C; Piñero JA; Calleja MA; Espin J; Arborio-Pinel R; Ariceta G
Orphanet J Rare Dis; 2022 Jul; 17(1):298. PubMed ID: 35906684
[TBL] [Abstract][Full Text] [Related]
5. Effect of Burosumab on Muscle Function and Strength, and Rates of ATP Synthesis in Skeletal Muscle in Adults With XLH.
Insogna KL; Sullivan R; Parziale S; Deng Y; Carrano D; Simpson C; Dufour S; Carpenter T; Petersen KF
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1061-e1071. PubMed ID: 37930769
[TBL] [Abstract][Full Text] [Related]
6. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).
Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP
J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300
[TBL] [Abstract][Full Text] [Related]
7. Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia.
Mindler GT; Kranzl A; Stauffer A; Kocijan R; Ganger R; Radler C; Haeusler G; Raimann A
Front Endocrinol (Lausanne); 2021; 12():754084. PubMed ID: 34646241
[TBL] [Abstract][Full Text] [Related]
8. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.
Che H; Roux C; Etcheto A; Rothenbuhler A; Kamenicky P; Linglart A; Briot K
Eur J Endocrinol; 2016 Mar; 174(3):325-33. PubMed ID: 26783348
[TBL] [Abstract][Full Text] [Related]
9. The ankle in XLH: Reduced motion, power and quality of life.
Akta C; Wenzel-Schwarz F; Stauffer A; Kranzl A; Raimann A; Kocijan R; Ganger R; Mindler GT
Front Endocrinol (Lausanne); 2023; 14():1111104. PubMed ID: 37033213
[TBL] [Abstract][Full Text] [Related]
10. Osteoarthritis, Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia.
Steele A; Gonzalez R; Garbalosa JC; Steigbigel K; Grgurich T; Parisi EJ; Feinn RS; Tommasini SM; Macica CM
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1798-814. PubMed ID: 32047911
[TBL] [Abstract][Full Text] [Related]
11. Disease-specific gait deviations in pediatric patients with X-linked hypophosphatemia.
Mindler GT; Kranzl A; Stauffer A; Haeusler G; Ganger R; Raimann A
Gait Posture; 2020 Sep; 81():78-84. PubMed ID: 32688230
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO;
J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries.
Al Juraibah F; Al Amiri E; Al Dubayee M; Al Jubeh J; Al Kandari H; Al Sagheir A; Al Shaikh A; Beshyah SA; Deeb A; Habeb A; Mustafa M; Zidan H; Mughal MZ
Arch Osteoporos; 2021 Mar; 16(1):52. PubMed ID: 33660084
[TBL] [Abstract][Full Text] [Related]
14. Bone microstructure evaluated by TBS and HR-pQCT in Chinese adults with X-linked hypophosphatemia.
Ni X; Guan W; Pang Q; Jin C; Gong Y; Liu W; Wang O; Li M; Xing X; Yu W; Jiang Y; Xia W
Bone; 2022 Jul; 160():116423. PubMed ID: 35439616
[TBL] [Abstract][Full Text] [Related]
15. Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study.
Scorcelletti M; Kara S; Zange J; Jordan J; Semler O; Schönau E; Rittweger J; Ireland A; Seefried L
Osteoporos Int; 2022 Jul; 33(7):1601-1611. PubMed ID: 35435480
[TBL] [Abstract][Full Text] [Related]
16. X-Linked Hypophosphatemia, Not Only a Skeletal Disease But Also a Chronic Inflammatory State.
Méaux MN; Alioli C; Linglart A; Lemoine S; Vignot E; Bertholet-Thomas A; Peyruchaud O; Flammier S; Machuca-Gayet I; Bacchetta J
J Clin Endocrinol Metab; 2022 Nov; 107(12):3275-3286. PubMed ID: 36112422
[TBL] [Abstract][Full Text] [Related]
17. Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study.
Lo SH; Lachmann R; Williams A; Piglowska N; Lloyd AJ
Qual Life Res; 2020 Jul; 29(7):1883-1893. PubMed ID: 32162120
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia.
Jiménez M; Ivanovic-Zuvic D; Loureiro C; Carvajal CA; Cavada G; Schneider P; Gallardo E; García C; Gonzalez G; Contreras O; Collins MT; Florenzano P
Osteoporos Int; 2021 Sep; 32(9):1825-1836. PubMed ID: 33666701
[TBL] [Abstract][Full Text] [Related]
19. Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points.
Theodore-Oklota C; Bonner N; Spencer H; Arbuckle R; Chen CY; Skrinar A
Value Health; 2018 Aug; 21(8):973-983. PubMed ID: 30098676
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population.
Rodríguez-Rubio E; Gil-Peña H; Chocron S; Madariaga L; de la Cerda-Ojeda F; Fernández-Fernández M; de Lucas-Collantes C; Gil M; Luis-Yanes MI; Vergara I; González-Rodríguez JD; Ferrando S; Antón-Gamero M; Carrasco Hidalgo-Barquero M; Fernández-Escribano A; Fernández-Maseda MÁ; Espinosa L; Oliet A; Vicente A; Ariceta G; Santos F;
Orphanet J Rare Dis; 2021 Feb; 16(1):104. PubMed ID: 33639975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
